We are delighted to announce that Aitia will be participating in the Sixth Annual International IP Summit. Our CEO, Colin Hill, will be a featured speaker at an engaging discussion titled: Leveraging AI in Healthcare and Life Sciences: Key Legal Considerations. Colin will be joined by industry experts Dr. Bernardo Bizzo, the Senior Director of Mass General Brigham, Sally Wang Liang, the Senior Vice President of Business Development & Head of Global Business Unit of PepLib, Christine Moundas, the Partner of Ropes & Gray, and James Yeagle, the Associate General Counsel of WHOOP.

AI has the potential to streamline healthcare processes from medical notetaking to drug design for biopharmaceutical companies. Due to a lack of regulation and government oversight, there have been increasing calls to analyze the risks of AI within these industries. In this discussion, we will delve into a compelling subject: the key legal considerations when applying AI in Healthcare and Life Sciences, such as accuracy and equity.

More information on the Sixth Annual International IP Summit here.